ESM1 anticorps

N° du produit ABIN1589852

Détail du produit anti-ESM1 anticorps

Antigène: ESM1 (Endothelial Cell-Specific Molecule 1 (ESM1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ESM1 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Fonction: Endocan/ESM-1 antibody

Specificité: Recombinant human ESM-1

Attributs du produit: Chromosomal location: 5q11.2

Purification: Protein A purified

Immunogène: Recombinant human ESM-1 (ABIN1589766)

Isotype: IgG

Information d'application

Indications d'application: Western Blot: Use 1-5 μg/mL

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: 0.5X PBS, pH 7.2

Conseil sur la manipulation: Centrifuge vial prior to opening. Avoid repeated freeze-thaw cycles.

Stock: 4 °C,-20 °C

Stockage commentaire: The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

Date de péremption: 24 months

Détails sur ESM1

Antigène: ESM1 (Endothelial Cell-Specific Molecule 1 (ESM1))

Autre désignation: Endocan/ESM-1 (ESM1 Produits)

Synonymes: anticorps ESM1, anticorps zgc:153027, anticorps 0610042H23Rik, anticorps AV004503, anticorps ESM-1, anticorps Pg25, anticorps endocan, anticorps endothelial cell specific molecule 1, anticorps endothelial cell-specific molecule 1, anticorps ESM1, anticorps esm1, anticorps Esm1

Sujet: Endocan, ESM1,Endocan, also known as endothelial cell specific molecule1 (ESM1), is a secreted cysteine-rich dermatan sulfate (DS) proteoglycan primarily expressed by endothelial cells within the vascular capillary network in kidney and in the alveolar walls of the lung. Endocan expression has also been detected in different epithelia and in adipocytes. The expression of endocan is upregulated by TNFα, IL1β, or lipopolysaccharide and downregulated by IFNγ. The human Endocan gene encodes a 184 amino acid (aa) residues precursor protein with a 19 aa hydrophobic signal peptide and a 165 aa mature region with 18 Cysteine residues. The DS chain is covalently attached to serine 137. Endocan has been shown to bind CD11a/CD18 integrin (also known as lymphocyte functionassociated antigen1, LFA1) on human lymphocytes, monocytes and Jurkat cells, inhibiting its binding to ICAM-1 and reducing LFA1-mediated leukocyte activation. Endocan binds via its DS chain to hepatocyte growth factor (HGF) to enhance HGF mitogenic activity. Genetically engineered cells overexpressing endocan has been shown to induce tumor formation, suggesting that Endocan may be involved in the pathophysiology of tumor growth in vivo. Circulating Endocan can be detected in the serum from healthy subjects. In patients with lung cancer or acute and severe sepsis, elevated Endocan concentrations have been reported.

ID gène: 11082

NCBI Accession: NM_007036, NP_008967

UniProt: Q9NQ30

Pathways: Growth Factor Binding